کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5559391 | 1561582 | 2016 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet](/preview/png/5559391.png)
- Esculetin markedly reduced diabetic heaptosteatosis.
- Esculetin decreased HbA1C levels in high-fat fed diabetic mice.
- Esculetin inhibited hepatic gluconeogenesis in high-fat fed diabetic mice.
- Esculetin suppressed inflammatory response in high-fat fed diabetic mice.
This study investigated the effects and mechanism of esculetin (6,7-dihydroxycoumarin) on non-alcoholic fatty liver in diabetic mice fed high-fat diet (HFD). The diabetic mice model was induced by injection of streptozotocin, after which they were fed HFD diet with or without esculetin for 11 weeks. Non-diabetic mice were provided a normal diet. Diabetes induced hepatic hypertrophy, lipid accumulation and droplets; however, esculetin reversed these changes. Esculetin treatment in diabetic mice fed HFD significantly down-regulated expression of lipid synthesis genes (Fasn, Dgat2 and Plpp2) and inflammation genes (Tlr4, Myd88, Nfkb, Tnfα and Il6). Moreover, the activities of hepatic lipid synthesis enzymes (fatty acid synthase and phosphatidate phosphohydrolase) and gluconeogenesis enzyme (glucose-6-phosphatase) in the esculetin group were decreased compared with the diabetic group. In addition, esculetin significantly reduced blood HbA1c, serum cytokines (TNF-α and IL-6) and chemokine (MCP-1) levels compared with the diabetic group without changing the insulin content in serum and the pancreas. Hepatic SOD activity was lower and lipid peroxidation level was higher in the diabetic group than in the normal group; however, esculetin attenuates these differences. Overall, these results demonstrated that esculetin supplementation could protect against development of non-alcoholic fatty liver in diabetes via regulation of lipids, glucose and inflammation.
318
Journal: Chemico-Biological Interactions - Volume 260, 25 December 2016, Pages 13-21